These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 205786)

  • 61. Analysis of F-wave in metabolic neuropathies: a comparative study in uremic and diabetic patients.
    Fierro B; Modica A; D'Arpa A; Santangelo R; Raimondo D
    Acta Neurol Scand; 1987 Mar; 75(3):179-85. PubMed ID: 3033975
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Control of uremic neuropathy by equilibrium peritoneal dialysis.
    Buoncristiani U; Mazzotta G; Carobi C; Gallai V; Cozzari M; Di Paolo NN
    Int J Artif Organs; 1984 Mar; 7(2):97-100. PubMed ID: 6329962
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Experimental uremic neuropathy. Part 1. Decreased nerve conduction velocity in rats.
    Tegnèr R; Brismar T
    J Neurol Sci; 1984 Jul; 65(1):29-36. PubMed ID: 6470744
    [TBL] [Abstract][Full Text] [Related]  

  • 64. On the pathogenesis of the uremic state. An exposition of the "trade-off hypothesis".
    Bricker NS
    N Engl J Med; 1972 May; 286(20):1093-9. PubMed ID: 4553202
    [No Abstract]   [Full Text] [Related]  

  • 65. Role of parathyroid hormone in the decreased motor nerve conduction velocity of chronic renal failure.
    Akmal M; Massry SG
    Proc Soc Exp Biol Med; 1990 Nov; 195(2):202-7. PubMed ID: 2236103
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Follow-up of nerve conduction in chronic uremic patients during hemodialysis.
    Leone M; Bottacchi E; Alloatti S; Nebiolo PE; Aimino M; Baldini S
    Ital J Neurol Sci; 1992 May; 13(4):317-21. PubMed ID: 1601630
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Dysfunction of polymorphonuclear leukocytes in uremia: role of parathyroid hormone.
    Massry S; Smogorzewski M
    Kidney Int Suppl; 2001 Feb; 78():S195-6. PubMed ID: 11169010
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Parathyroid hormone and the uremic manifestations.
    Massry SG
    Contrib Nephrol; 1980; 20():84-91. PubMed ID: 6249538
    [No Abstract]   [Full Text] [Related]  

  • 69. Parathyroid hormone, uremia, and the nervous system.
    Goldstein DA; Massry SG
    Contrib Nephrol; 1980; 20():73-83. PubMed ID: 6995014
    [No Abstract]   [Full Text] [Related]  

  • 70. [Uremic toxin and dialysis].
    Kobayashi K; Maeda K; Kawaguchi S
    Nihon Jinzo Gakkai Shi; 1976 Jun; 18(6):412-4. PubMed ID: 988343
    [No Abstract]   [Full Text] [Related]  

  • 71. Vibratory perception threshold compared with nerve conduction velocity in the evaluation of uremic neuropathy.
    Tegnér R; Lindholm B
    Acta Neurol Scand; 1985 Apr; 71(4):284-9. PubMed ID: 4003031
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Calcium-stimulated vasopressin secretion in uremic patients: an effect mediated via parathyroid hormone?
    Hammer M; Ladefoged J; Madsen S; Olgaard K; Tvedegaard E
    J Clin Endocrinol Metab; 1980 Nov; 51(5):1078-84. PubMed ID: 7419683
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Serum magnesium and nerve conduction velocity in uraemic patients on chronic haemodialysis.
    Cisari C; Gasco P; Calabrese G; Pratesi G; Gonella M
    Magnes Res; 1989 Dec; 2(4):267-9. PubMed ID: 2642071
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Uremic neuropathy--I. Is uremic neuropathy related to patient age, duration of nephropathy and dialysis treatment?].
    Jedras M; Zakrzewska-Pniewska B; Wardyn K; Switalski M
    Pol Arch Med Wewn; 1998 Jun; 99(6):452-61. PubMed ID: 10085699
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Role of uremic toxins in exacerbating anemia in renal failure.
    Macdougall IC
    Kidney Int Suppl; 2001 Feb; 78():S67-72. PubMed ID: 11168986
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Diminished parathyroid gland responsiveness to hypocalcemia in diabetic patients with uremia.
    Heidbreder E; Götz R; Schafferhans K; Heidland A
    Nephron; 1986; 42(4):285-9. PubMed ID: 3960240
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Parathyroid hormone and the altered vascular response to norepinephrine in uremia.
    Collins J; Massry SG; Campese VM
    Am J Nephrol; 1985; 5(2):110-3. PubMed ID: 3993699
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Decrease of tumor-like calcification in uremia despite aggravation of secondary hyperparathyroidism: a case report.
    Geffriaud C; Allinne E; Page B; Zingraff J; Jucquel JP; Bardin T; Drüeke TB
    Clin Nephrol; 1992 Sep; 38(3):158-61. PubMed ID: 1395170
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Uremic neuropathy. III. Controlled study of restricted protein and fluid diet and infrequent hemodialysis versus conventional hemodialysis treatment.
    Dyck PJ; Johnson WJ; Nelson RA; Lambert EH; O'Brien PC
    Mayo Clin Proc; 1975 Nov; 50(11):641-9. PubMed ID: 171524
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effects of hemodialytic treatment on uremic polyneuropathy. A clinical and electrophysiological follow-up study.
    Caccia MR; Mangili A; Mecca G; Ubiali E; Zanoni P
    J Neurol; 1977 Dec; 217(2):123-31. PubMed ID: 75258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.